Article Sidebar
Published:
Mar 6, 2025DOI:
10.4314/emj.v63i1.5Keywords:
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of the published papers and grant to the publisher the non-exclusive right to publish the article, to be cited as its original publisher in case of reuse, and to distribute it in all forms and media. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with the original article published in the Ethiopian Medical Journal. Authors can enter separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of their work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Main Article Content
A comparative study of the effects of adding intrathecal morphine and pethidine to bupivacaine in spinal anesthesia during cesarean section: A randomized clinical trial
Abstract
Background: Intrathecal opioids are routinely used during spinal anesthesia for post cesarean analgesia. In this research, the analgesic effects of adding pethidine or morphine to intrathecal bupivacaine have been compared. Methods: In a double-blinded, randomized trial, 110 parturients who were scheduled for elective cesarean section were randomized into two groups of 55 patients each. In one group, 12 mg of bupivacaine (0.5%) plus 200 mcg of intrathecal morphine and in the second group 12 mg of bupivacaine (0.5%) plus 20 mg of pethidine in a total volume of 3 cc was injected as an intrathecal injection. Data variables were recorded at 1st, 4th, and 24th hours postoperatively. The primary outcome was the pain intensity numerical rating scale (0-10). The secondary outcomes were nausea, vomiting, itching, sedation (Ramsey Sedation Scale), shivering, and demand for analgesic medication.
Results: No statistically significant differences were found between the two groups in terms of shivering, sedation, pain and pain severity, duration of painlessness period, number of demanded analgesics and level of sensory block, at 1st, 4th, and 24th hours post-operatively. At 24 hours after surgery, the rate of nausea and vomiting was significantly lower in the pethidine group (3 vs. 11, p=0.02), but at the same time, itching complaints were higher in the morphine group (10 vs. 0, p=0.001).
Conclusion: Adding intrathecal morphine and pethidine to bupivacaine in spinal anesthesia for cesarean section both creates a long-term and acceptable analgesia. However, in controlling itching, nausea and vomiting, pethidine showed to be more effective than morphine. Thus, it is suggested that 12 mg of bupivacaine (0.5%) is applied in combination with 20 mg of pethidine in spinal anesthesia for this surgery.
